Clinical Trials

Status
Title Intervention Sponsor Status
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Questionnaire Administration, Placebo Administration, Biospecimen Collection, Rectal Biopsy National Cancer Institute (NCI) Active, not recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration National Cancer Institute (NCI) Active, not recruiting
ASPirin Intervention for the REDuction of Colorectal Cancer Risk Placebo for Aspirin, Aspirin Massachusetts General Hospital Active, not recruiting
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP, Questionnaire Administration National Cancer Institute (NCI) Recruiting
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts Paclitaxel + Gemcitabine admixture, Ethanol, Normal saline Milton S. Hershey Medical Center Recruiting
Chemoprevention of Gastric Carcinogenesis Eflornithine, Eflornithine placebo Vanderbilt-Ingram Cancer Center Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration National Cancer Institute (NCI) Active, not recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Erlotinib National Cancer Institute (NCI) Active, not recruiting